Efficacy of topical formulation of Atorvastatin 1% in bed sore healing
Not Applicable
- Conditions
- Decubitus ulcer (Pressure ulcer )Grade 1 or 2 bed sore.
- Registration Number
- IRCT201102273449N4
- Lead Sponsor
- Pharmaceutical Research Center, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Grade 1 or 2 bed sore diagnosed by the pharmacist according to The 2-digit Stirling scale
Exclusion criteria: pregnancy or lactation, hypersensitivity reaction to topical formulation, elevated ALT and/or AST to more than 3 times the upper limit of normal with clinical manifestations of liver failure or more than 5 times the upper limit of normal without clinical manifestations of liver failure, unwillingness for entering in the study or discontinuation of follow up
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Grade of bed sore. Timepoint: 7 and 14 days after topical formulation. Method of measurement: evaluationof bed sore grade according to The 2-digit Stirling scale by pharmacist.
- Secondary Outcome Measures
Name Time Method